Spyre Therapeutics Inc 2024年度报告

=>?@ABC@DEFGHEIJKBL@CB@KKMEAJGJENJCJBKAO@LBELP""""""""""""""""""""""""""""""""""""""""""""""""""""""""" $!*#$!*/2Q./R%*$:S:$ ./1/ .// + /./.T9.,101.7...U-+< <<4723/.,/01<-V92,* 9/$24 * +,,./0).172W/19X/001/- +Y7,/-/.Z/2/7/945/.129,./1,/[+R$:-R$%! /19././/./,79.9 /1$+5-0/W1/ 1[2/0/112., 3452+-4/0/1/W1/Q1.//./,\FDDFC]BFA^_`abaaacd@Le@fgEdEL]O@LE]hH>iOEj@KN@k]BFA^l@L^EBmm\=j@KN@knfFo@f]EfEABl@L^EBP /19././/./,79.9 /1$+-0/W1/ 1[/"""""""""""""""""""""""""""""""""""""""""""""""""""""""""pCNJA@BEoqAOEA^D@L^JGBOEHEIJKBL@CBJK@rEffs^CFrCKE@KFCENJKKgEL_@KNEGJCENJCHgfEtauFGBOE]EAgLJBJEKpCNJA@BEoqAOEA^D@L^JGBOEHEIJKBL@CBJKCFBLEkgJLENBFGJfELEMFLBKMgLKg@CBBF]EABJFCcxFLcu=NPFGBOE>?AO@CIEvABbhEK6jF wpCNJA@BEoqAOEA^D@L^rOEBOELBOEHEIJKBL@CB=cPO@KGJfEN@ffLEMFLBKLEkgJLENBFoEGJfENoq]EABJFCcxFLcu=NPFGBOE]EAgLJBJEK>?AO@CIEvABFGcyxtNgLJCIBOEMLEAENJCIczDFCBOK=FLGFLKgAOKOFLBELMELJFNBO@BBOEHEIJKBL@CBr@KLEkgJLENBFGJfEKgAOLEMFLBKP_@CN=zPO@KoEECKgo{EABBFKgAOGJfJCILEkgJLEDECBKGFLBOEM@KByaN@qKbhEKwjF6pCNJA@BEoqAOEA^D@L^rOEBOELBOEHEIJKBL@CBO@KKgoDJBBENEfEABLFCJA@ffqE|ELqpCBEL@ABJ|E}@B@~JfELEkgJLENBF vABbhEK6jF woEKgoDJBBENMgLKg@CBBFHgfEtauFGHEIgf@BJFC]si=zxzbtauFGBOJKAO@MBELPNgLJCIBOEMLEAENJCIczDFCBOK=FLGFLKgAOKOFLBELMELJFNBO@BBOEHEIJKBL@CBr@KLEkgJLENBFKgoDJBKgAOGJfEKPbhEKwjF6pCNJA@BEoqAOEA^D@L^rOEBOELBOEHEIJKBL@CBJK@f@LIE@AAEfEL@BENGJfEL_@C@AAEfEL@BENGJfEL_@CFCs@AAEfEL@BENGJfEL_@KD@ffELLEMFLBJCIAFDM@Cq_FL@CEDELIJCIILFrBOAFDM@Cqb]EEBOENEGJCJBJFCKFG€f@LIE@AAEfEL@BENGJfEL_€@AAEfEL@BENGJfEL_€KD@ffELLEMFLBJCIAFDM@Cq_@CN€EDELIJCIILFrBOAFDM@CqJCHgfEczoszFGBOE>?AO@CIEvABbm@LIE@AAEfEL@BENGJfELwvAAEfEL@BENGJfEL6jFCs@AAEfEL@BENGJfEL6]D@ffELLEMFLBJCIAFDM@Cq6>DELIJCIILFrBOAFDM@Cq6 pG@CEDELIJCIILFrBOAFDM@Cq_JCNJA@BEoqAOEA^D@L^JGBOEHEIJKBL@CBO@KEfEABENCFBBFgKEBOEE?BECNENBL@CKJBJFCMELJFNGFLAFDMfqJCIrJBO@CqCEr FLLE|JKENGJC@CAJ@f@AAFgCBJCIKB@CN@LNKMLF|JNENMgLKg@CBBF]EABJFCcx=@PFGBOE>?AO@CIEvABb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